Skip to main content
. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495

Figure 1. Prevalence of TDRM by drug classes in three risk groups.

Figure 1

Prevalences are shown of resistance to at least one of the drug classes (Any), nucleoside reverse transcriptase inhibitor (NRTI), non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI) in men who have sex with men (MSM), heterosexuals (HSX), and injection drug users (IDU). * = p<0.001 in comparison with MSM